Patents Assigned to GUANGZHOU JOYO PHARMATECH CO., LTD.
  • USE OF PYRROLOPYRIMIDINE COMPOUND
    Publication number: 20240238299
    Abstract: Provided is the use of a pyrrolopyrimidine compound. The structure of the pyrrolopyrimidine compound is as represented by formula I, which compound has the effect of inhibiting the phosphorylation of STAT, and has a good prevention or treatment effect on suppurative myelitis, acute myelitis, encephalomyelitis or autoimmune diseases.
    Type: Application
    Filed: May 20, 2022
    Publication date: July 18, 2024
    Applicant: GUANGZHOU JOYO PHARMATECH CO., LTD
    Inventors: Yongguo LI, Xiaoning CHEN
  • USE OF PYRIDONE DERIVATIVE CONTAINING HETEROATOM CYCLOBUTANE SUBSTITUENT
    Publication number: 20240238263
    Abstract: Disclosed is the use of a pyridone derivative containing a heteroatom cyclobutane substituent. Disclosed is the use of substance A in the preparation of a drug. Substance A is a compound as represented by formula I, a pharmaceutically acceptable salt thereof, a solvate thereof, or a solvate of the pharmaceutically acceptable salt thereof. The drug is the drug for treating and/or preventing diabetic feet. The disclosed substance A or the drug containing substance A has good activity on patients with a diabetic foot.
    Type: Application
    Filed: May 20, 2022
    Publication date: July 18, 2024
    Applicant: GUANGZHOU JOYO PHARMATECH CO., LTD
    Inventors: Yongguo LI, Xiaoning CHEN, Hongyan MA
  • APPLICATION OF HETEROCYCLIC COMPOUND
    Publication number: 20230165864
    Abstract: An application of a heterocyclic compound. An application of a substance Y in the preparation of drugs for raising blood sugar. The compound can be used to raise blood sugar and treat hypoglycemia or congenital hyperinsulinism.
    Type: Application
    Filed: April 29, 2021
    Publication date: June 1, 2023
    Applicants: GUANGZHOU JOYO PHARMATECH CO., LTD, SHANGHAI JIA TAN PHARMATECH CO., LTD.
    Inventors: Yongguo LI, Gang LU, Lei LI, Wei WEI, Zhen GE
  • Crystal form and salt form of pyridone compound and preparation method therefor
    Patent number: 11198686
    Abstract: A crystal form of a compound 1 and a method for preparing the same, further comprising an application of the crystal form in the preparation of a drug for treating diseases associated with fibrosis.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: December 14, 2021
    Assignees: GUANGZHOU JOYO PHARMATECH CO., LTD., SHLIAZHUANG SAGACITY NEW DRUG DEVELOPMENT CO., LTD., MEDSHINE DISCOVERY INC.
    Inventors: Lei Zhang, Bin Chen, Yangguang Zhao, Jian Li, Shuhui Chen